The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2"…
- Investigators
- Adolfo Ramirez-Zamora, Irene A Malaty
- Status
- Accepting Candidates
- Ages
- 40 Years - 80 Years
- Sexes
- All